Buying Time: Longevity Moves Into Real Estate
- Longevity Investors
- 32 minutes ago
- 12 min read
Longevity is moving out of the clinic and into the places people live. A new category of health-led homes is forming, drawing serious capital along with its own definitions and, now, regulation. For the longevity field it is both an opportunity and a familiar test: telling the projects that fund the science from those that only borrow its language. For most of the past decade, longevity has been a science and a clinic. It is now also becoming a place to live. Developers in a handful of markets are building homes, and in some cases whole communities, around the promise of a longer and healthier life, with diagnostics, preventive programmes and health-led design built into the property itself.
For the longevity field, this matters in a specific way. The thesis is leaving the lab and the supplement aisle and entering the built environment, where people spend most of their lives. That turns a home from a static asset into something closer to a health platform, opens a new channel for capital into longevity, and brings with it the problem the field already knows well: telling what genuinely works from what is merely marketed. Over the past year the category has acquired the three things it previously lacked: hard measurement, a formal definition, and institutional capital.
What the Premium Pays For
Everything in the category is priced off a single number, and it is worth saying plainly what that number means. The branded residence premium is the extra a buyer pays for a home carrying a hotel, wellness or luxury name, set against an otherwise identical home in the same market with none. If the unbranded apartment sells for three million dollars and the branded one for four, the premium is a third.
By that measure the market is uneven. Savills puts the global average at 30 to 33 percent, but the average hides most of the picture. In London, where the surrounding stock is already excellent and the badge adds little, the premium is about 8 percent, and in parts of New York it disappears, with a few exceptional unbranded buildings selling for more than branded ones. In less-established markets it rises to an average of 44 to 54 percent, because there the brand supplies what the local market cannot promise on its own: build quality, security, service, and the confidence the asset will resell. In Dubai, the busiest market in the sector, some schemes have sold at premiums near 90 percent. The same brand commands a negligible premium in one city and nearly double the price in another. Health and longevity positioning then adds a further layer, with the Global Wellness Institute measuring an additional 10 to 25 percent for homes genuinely built around it.
The premium, then, is real. What tends to go unexamined is that it is not one thing but three, bundled into a single price.
The first is brand and scarcity: assured quality, limited supply, security, and resale liquidity, which is why buyers in thinner markets pay the most, buying certainty as much as space. The second is the physical building, its air, water, light and layout, the part almost every account skips and the part the research speaks to directly. The third is a clinical and service operation that has to be staffed and run every year after the sale closes.
That third component is the one investors most often underestimate. A 2026 analysis of the sector put it precisely: "The premium is real. So is what you are paying to generate it." Licensing fees, royalties, technical-service agreements, brand-mandated specifications and the standing cost of a real medical operation all sit beneath the headline number. The premium is not free margin. It is a commitment that has to be funded continuously, and it holds only while the delivered experience matches the marketed one. Where the operation is thin, the cost remains and the premium erodes. That single mechanism, more than any design trend, is what separates durable assets from write-downs.
What the Built Environment Measurably Does
The line between a longevity residence and an expensive metaphor is drawn by evidence, and the evidence is stronger than most buyers realise. The inputs these buildings sell have been measured, and they move real markers of health.
The most rigorous work comes from the COGfx programme at the Harvard T.H. Chan School of Public Health, a multi-year, NIH-funded study of indoor environmental quality. In controlled conditions, moving people from a conventional building into a well-ventilated, low-pollutant one roughly doubled their cognitive-function scores. In occupied buildings the effect held: residents of green-certified spaces scored about 26 percent higher on cognitive tests, reported roughly 30 percent fewer sick-building symptoms, and slept measurably better, by around 6 percent, than occupants of otherwise comparable buildings. A later study across a hundred buildings found the relationship was linear: as fine particulate matter and carbon dioxide rose, cognitive performance fell. Ventilation and filtration are not comfort features. They are cognitive inputs.
The effect extends beyond the front door. A systematic review of fifty-six studies on the neighbourhood built environment and cognition in older adults found green space, walkability and access to daily destinations consistently linked to sharper cognition and lower dementia risk, while living beside a heavily trafficked road, a fair proxy for chronic air-pollution exposure, ran the other way. This is the evidence behind terms like biophilic design and access to nature: across a life, the built environment is an active variable in how a brain ages, not a decorative one.
None of this proves a particular residence adds years to a life. It proves something an allocator can use: air, water, light, greenery and movement are levers with measured effects on cognition, sleep and long-term brain health. A building genuinely engineered around them delivers a health input, not a story, and the difference between a project that installs and monitors those systems and one that only markets them is a real, testable gap.
A Category, Newly Defined
For all the money, the category spent years without a definition, which is what let the marketing run ahead of the substance. That changed in April 2026, when the Global Wellness Institute formally designated "longevity residences" as a distinct sub-category, separated from the broader wellness housing market. Its criteria are deliberately harder to meet than a brochure: a genuine clinical layer, health infrastructure inside the residence rather than nearby, structured preventive programming such as biomarker monitoring and personalized protocols, environmental design engineered for long-term health, and named medical oversight. Under that framing the home becomes part of the longevity system, supporting sleep, metabolic health and cognition through design and data.
The definition is now being reinforced from an unexpected direction: regulation. The Department of Health – Abu Dhabi has introduced what it calls the world's first licensing framework for Healthy Longevity Medicine Centres, with clinical guidelines effective from April 2025 and the first regulated longevity clinic already licensed under it. Where the Global Wellness Institute defined the residence, a government has begun defining the clinical layer those residences depend on, setting minimum standards for diagnostics, intervention and governance. For a category whose defining risk is the unfunded claim, a licensing regime is a serious signal: the medical component is moving from marketing into regulated practice, and the projects that carry a real clinical layer will increasingly be measured against a standard.
What It Looks Like in Practice
The category is still young, which makes its live projects more instructive than any forecast, and they run from single buildings to whole islands. The most ambitious is SHA Residences Emirates Island, developed by the Abu Dhabi group IMKAN and anchored by the SHA Wellness Clinic, marketed as the first island built entirely around longevity: 137 homes at AlJurf on the coast between Dubai and Abu Dhabi, priced from roughly $2.5 to $35 million, with first occupancy in 2027 and sales led by Knight Frank. It extends a lineage that began as a clinic in Spain and a residential project in Mexico, and residents are promised standing access to SHA's diagnostics and longevity programmes in homes built with air purification, circadian lighting and passive environmental design.
Others work the same idea at smaller scale. Six Senses Residences carries hospitality health infrastructure into standalone homes. In Milan, the biohacking clinic The Longevity Suite has partnered with the design house Visionnaire to build the health systems into the architecture from the first drawings rather than the final fit-out, with Dubai, Riyadh and Miami to follow. And in Dubai, R.Evolution's Eywa frames the idea most explicitly of any of them. It calls itself regenerative real estate and treats architecture as a carrier of health, designing wellbeing in as a measurable asset rather than a closing amenity, an approach it sums up as real estate becoming infrastructure for health. Eywa is a partner of Longevity Investors, which publishes this newsletter. The scale differs across these projects; the thesis is the same. The building is the product, and health is what it is for.
Why Capital Is Committing
The pipeline shows the shift clearly. Savills counts branded residences rising from 323 projects in 2015 to more than 900 in 2025, with the forward pipeline pointing at roughly 1,750 by 2032. Projects with no attached hotel now make up more than 40 percent of new launches, up from 15 percent in 2018, a sign that health-led living has become a reason to build rather than a feature added to a resort. And the money behind it is changing character, moving from one-off trophy purchases into dedicated funds, REIT structures and family-office co-investment, the point at which a theme becomes an asset class.
The engine is demographic. An ageing ultra-high-net-worth population increasingly puts health and life extension at the top of its priorities and wants that priority built into where it lives, not booked as a retreat. The market around it is large: UBS Global Wealth Management sizes the global longevity economy at $5.3 trillion in 2023, rising toward $8 trillion by 2030. In its 2026 Mid-Year Luxury Outlook, Sotheby's International Realty found longevity had become a primary organizing principle for decisions at the top of the market, a shift its chief marketing officer, Brad Nelson, summarized as: "Wellness is no longer an amenity; it's the organizing principle." For the family offices and funds that gather each year at the Longevity Investors Conference, this crossover of property, hospitality and preventive health is now one of the clearer patterns in how longevity capital moves, concentrated in the same regions, the Gulf among them, where much of that community already sits.
Where the Return Lives
For an investor, the category poses a structural question before a selection one: which layer to own. Public markets offer only indirect exposure. The listed proxies, health and wellness infrastructure REITs such as Welltower, Ventas and Healthpeak, or the life-science landlord Alexandria, hold senior housing, medical offices and lab campuses rather than the residences described here; they offer liquidity, a dividend and the same demographic tailwind, judged on funds from operations and occupancy rather than earnings, but they are interest-rate sensitive and a step removed from the category itself, which is still mostly private and early. Direct exposure runs through unit ownership, developer and joint-venture equity, private real estate funds and private credit, typically accredited or family-office capital from around $100,000, and, closest to the longevity thesis itself, equity in the operating and clinical platforms such as SHA and The Longevity Suite.
The more important question is where the return originates, and the answer is two places, not one. A health-led residence produces both the real estate, through rent or appreciation, and a care-and-service business, through recurring wellness and clinical fees. The development premium is the visible return; the recurring operating income is the durable one, and also the part that must be earned again each year. The structural choice mirrors senior housing: a net-lease position that pays predictable rent and caps the upside while the operator carries the operations, or an operating position of the kind RIDEA structures allow, which shares in occupancy and service income with more upside and more exposure to execution. The lesson from that more mature sector is consistent: the return follows the operator, not the building. Occupancy, pricing power and resale retention all depend on whether the platform performs, which puts the decisive variable on familiar ground for a longevity investor.
The risks are specific. Private positions are illiquid and long; the listed proxies carry interest-rate and rotation risk; and every position carries operator and execution risk, because the premium erodes where the operation is thin. The pipeline is geographically concentrated, with a disproportionate share in a handful of markets, Dubai foremost. And wherever a real clinical layer exists, so does regulatory and licensing exposure that a plain real estate asset does not carry.
Separating Substance From Signage
This is where the premium is settled. The same uplift that rewards a genuine operator tempts the developments that want the price without funding the programme, and the difference between them is visible to anyone who knows what to look for. The weaker project is recognizable: a spa render, a single partner logo, one familiar wellness name and a line about an integrated philosophy, with no named medical director behind it, no published protocol, no clinical infrastructure beyond a better air filter, and no recurring wellness fee, the last being the clearest sign a programme exists to be paid for at all.
The diligence is the same the longevity field applies to any claim. Whether there is an operator or only a brand. Whether the infrastructure sits inside the residence or a drive away. Whether a clinical layer exists under real physician oversight, with protocols on paper. Whether a named person is accountable for the health programme. It is the same discipline the investors at the Longevity Investors Conference apply to the science each year, telling a genuine result from an expensive one, now pointed at concrete and square metres.
Resale will settle it over time. Branded and health-led residences have historically held value better and proved more resilient in downturns, but only where the service matched the promise. Over the next two to three years the data will separate the field: the operator-led projects should keep their premium, while those that priced the story without building the substance see it compress as buyers learn to tell the two apart. For the investor, that slow sorting is less a warning than the opportunity in the category.
What It Means for Longevity
Step back from the individual projects and the significance is larger than any one of them. Longevity real estate is the clearest sign that longevity is no longer only a science or a therapy. It is becoming infrastructure, built into where people live, and something capital can own directly.
For investors, that opens a route into the thesis that early-stage biotechnology does not offer. Where a longevity drug is a binary, illiquid and long-dated bet, a health-led residence is a real asset with recurring revenue and a resident who has already self-selected on healthspan. It is the same underlying trend expressed as cash flow rather than a single trial result, which is why it increasingly sits alongside biotech in longevity portfolios rather than in place of it.
For the field, the arrival of real estate is a double-edged marker of maturity. It brings scale, mainstream attention and, in Abu Dhabi's licensing framework, the beginnings of regulation, all of which add credibility. It also invites the dilution that follows any fast-growing category: projects that borrow longevity's language without funding its substance, and that dilution can cost the field the credibility the science has worked to build. Which is why the discipline matters. The same judgment a serious investor brings to a molecule, evidence over enthusiasm and operator over brand, now applies to a building. Applied well, longevity real estate is one of the most tangible ways to back longer, healthier lives. Applied carelessly, it is an expensive lobby with good lighting.
It is among the questions the Longevity Investors Conference takes up each September in Gstaad, where the investors funding this convergence, across property, hospitality and preventive health, weigh it against the evidence rather than the marketing.
In partnership with Eywa by R.Evolution. Eywa is the Dubai development where longevity capital meets conscious architecture, real estate built as infrastructure for health, sustainability and long-term value. Explore the project at longevityinvestors.ch/eywa.
References
[1] Robb Report. How the Longevity Movement Is Transforming Luxury Real Estate (Sotheby's International Realty 2026 Mid-Year Luxury Outlook; Brad Nelson). https://robbreport.com/shelter/home-design/longevity-luxury-real-estate-report-1238324517/
[2] InvestmentNews. How longevity is reshaping what wealthy clients want from real estate in 2026Â (Sotheby's outlook; UBS global longevity market $5.3T to $8T). https://www.investmentnews.com/alternatives/how-longevity-is-reshaping-what-wealthy-clients-want-from-real-estate-in-2026/267025
[3] Savills World Research. Branded residence price premiums (average, emerging-market and Dubai premiums; value retention). https://www.savills.com/research_articles/255800/333821-0
[4] Brand-Atlas. The Real Cost of Going Branded: A Deep Dive (composition of the premium; durability and resale). https://www.brand-atlas.com/journal/real-cost-branded-residences-premium-analysis
[5] Harvard T.H. Chan School of Public Health. The COGfx Study (indoor air quality, ventilation and cognitive function). https://healthybuildings.hsph.harvard.edu/research/indoor-air-quality/cogfx/
[6] Effects of neighborhood built environment on cognitive function in older adults: a systematic review (56 studies; green space, walkability, road proximity). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898015/
[7] Global Wellness Institute. Wellness Communities and Real Estate Initiative Trends for 2026Â (the designation of "longevity residences"). https://globalwellnessinstitute.org/global-wellness-institute-blog/2026/04/07/wellness-communities-and-real-estate-initiative-trends-for-2026/
[8] WWD. Wellness Is Integrating Its Ethos Into Branded Residences (Savills branded residence counts; The Longevity Suite and Visionnaire). https://wwd.com/home-design/architecture/wellness-integrating-ethos-branded-residences-1238567342/
[9] Brightwill. Wellness Real Estate 2026: The HNW Buyer's Guide (Global Wellness Institute wellness real estate sizing; SHA Residences). https://www.brightwillluxury.com/journal/wellness-real-estate
[10] PR Newswire / Knight Frank. Knight Frank appointed to lead launch of the Residences of SHA Island (SHA Residences Emirates Island; IMKAN; 137 residences; AED 9M to 130M; 2027 occupancy). https://www.prnewswire.com/news-releases/knight-frank-appointed-to-lead-launch-of-residences-of-sha-island--the-worlds-first-longevity--wellbeing-island-302556341.html
[11] Department of Health – Abu Dhabi. Abu Dhabi sets standards for the world's first Healthy Longevity Medicine Centres (licensing framework; clinical guidelines effective April 2025). https://www.doh.gov.ae/en/news/abu-dhabi-sets-standards-for-the-world-first-healthy-longevity-medicine-centres